219 related articles for article (PubMed ID: 34957212)
1. Cervical Cancer, Papillomavirus, and miRNA Dysfunction.
Bañuelos-Villegas EG; Pérez-yPérez MF; Alvarez-Salas LM
Front Mol Biosci; 2021; 8():758337. PubMed ID: 34957212
[TBL] [Abstract][Full Text] [Related]
2. Differential Expression of MicroRNAs in Uterine Cervical Cancer and Its Implications in Carcinogenesis; An Integrative Approach.
Nair VB; Manasa VG; Sinto MS; Jayasree K; James FV; Kannan S
Int J Gynecol Cancer; 2018 Mar; 28(3):553-562. PubMed ID: 29466255
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide discovery of viral microRNAs based on phylogenetic analysis and structural evolution of various human papillomavirus subtypes.
Weng SL; Huang KY; Weng JT; Hung FY; Chang TH; Lee TY
Brief Bioinform; 2018 Nov; 19(6):1102-1114. PubMed ID: 28531277
[TBL] [Abstract][Full Text] [Related]
4. Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes; a feasibility study.
Babion I; Snoek BC; Novianti PW; Jaspers A; van Trommel N; Heideman DAM; Meijer CJLM; Snijders PJF; Steenbergen RDM; Wilting SM
Clin Epigenetics; 2018; 10():76. PubMed ID: 29930741
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-Based Fingerprinting of Cervical Lesions and Cancer.
Pisarska J; Baldy-Chudzik K
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33203149
[TBL] [Abstract][Full Text] [Related]
6. The Role of microRNAs, Long Non-coding RNAs, and Circular RNAs in Cervical Cancer.
Tornesello ML; Faraonio R; Buonaguro L; Annunziata C; Starita N; Cerasuolo A; Pezzuto F; Tornesello AL; Buonaguro FM
Front Oncol; 2020; 10():150. PubMed ID: 32154165
[TBL] [Abstract][Full Text] [Related]
7. Identification of Novel Long Non-coding and Circular RNAs in Human Papillomavirus-Mediated Cervical Cancer.
Wang H; Zhao Y; Chen M; Cui J
Front Microbiol; 2017; 8():1720. PubMed ID: 28970820
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs as markers of progression in cervical cancer: a systematic review.
Pardini B; De Maria D; Francavilla A; Di Gaetano C; Ronco G; Naccarati A
BMC Cancer; 2018 Jun; 18(1):696. PubMed ID: 29945565
[TBL] [Abstract][Full Text] [Related]
9. Role of miRNAs in cervical cancer: A comprehensive novel approach from pathogenesis to therapy.
Abbas M; Mehdi A; Khan FH; Verma S; Ahmad A; Khatoon F; Raza ST; Afreen S; Glynn SA; Mahdi F
J Gynecol Obstet Hum Reprod; 2021 Nov; 50(9):102159. PubMed ID: 33965650
[TBL] [Abstract][Full Text] [Related]
10. Lack of Conserved miRNA Deregulation in HPV-Induced Squamous Cell Carcinomas.
Nunvar J; Pagacova L; Vojtechova Z; Azevedo NTD; Smahelova J; Salakova M; Tachezy R
Biomolecules; 2021 May; 11(5):. PubMed ID: 34065237
[TBL] [Abstract][Full Text] [Related]
11. From squamous intraepithelial lesions to cervical cancer: Circulating microRNAs as potential biomarkers in cervical carcinogenesis.
Berti FCB; Salviano-Silva A; Beckert HC; de Oliveira KB; Cipolla GA; Malheiros D
Biochim Biophys Acta Rev Cancer; 2019 Dec; 1872(2):188306. PubMed ID: 31398380
[TBL] [Abstract][Full Text] [Related]
12. The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions.
Sommerova L; Anton M; Bouchalova P; Jasickova H; Rak V; Jandakova E; Selingerova I; Bartosik M; Vojtesek B; Hrstka R
Antiviral Res; 2019 Mar; 163():185-192. PubMed ID: 30711417
[TBL] [Abstract][Full Text] [Related]
13. Association of variants of miRNA processing genes with cervical precancerous lesion risk in a southern Chinese population.
Huang SQ; Zhou ZX; Zheng SL; Liu DD; Ye XH; Zeng CL; Han YJ; Wen ZH; Zou XQ; Wu J; Liu YM; Huang CC; Wang Y; Yang G; Jing CX
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29853562
[TBL] [Abstract][Full Text] [Related]
14. miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA.
Xia YF; Pei GH; Wang N; Che YC; Yu FS; Yin FF; Liu HX; Luo B; Wang YK
Virol J; 2017 Feb; 14(1):20. PubMed ID: 28160779
[TBL] [Abstract][Full Text] [Related]
15. A Comprehensive Review of Dysregulated miRNAs Involved in Cervical Cancer.
Sharma G; Dua P; Agarwal SM
Curr Genomics; 2014 Aug; 15(4):310-23. PubMed ID: 25132800
[TBL] [Abstract][Full Text] [Related]
16. Role of microRNAs in gynecological pathology.
Gilabert-Estelles J; Braza-Boils A; Ramon LA; Zorio E; Medina P; Espana F; Estelles A
Curr Med Chem; 2012; 19(15):2406-13. PubMed ID: 22455593
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus genotype distribution and human papillomavirus 16 and human papillomavirus 18 genomic integration in invasive and in situ cervical carcinoma in human immunodeficiency virus-infected women.
Darwich L; Cañadas MP; Sirera G; Alameda F; Forcada P; Delas J; Fernández I; Llatjós M; Coll J; Clotet B; Videla S
Int J Gynecol Cancer; 2011 Nov; 21(8):1486-90. PubMed ID: 21892092
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells.
Martinez I; Gardiner AS; Board KF; Monzon FA; Edwards RP; Khan SA
Oncogene; 2008 Apr; 27(18):2575-82. PubMed ID: 17998940
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms in progression of HPV-associated cervical carcinogenesis.
Gupta SM; Mania-Pramanik J
J Biomed Sci; 2019 Apr; 26(1):28. PubMed ID: 31014351
[TBL] [Abstract][Full Text] [Related]
20. Integrated analysis of key microRNAs /TFs /mRNAs/ in HPV-positive cervical cancer based on microRNA sequencing and bioinformatics analysis.
Yuan Y; Shi X; Li B; Peng M; Zhu T; Lv G; Liu L; Jin H; Li L; Qin D
Pathol Res Pract; 2020 Jun; 216(6):152952. PubMed ID: 32307200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
